The patients were followed for 2 weeks after admission to the hospital for functional prognosis, and serum ICAM3 concentrations were found to be independent of stroke severity at baseline according to the National Institutes of Health Stroke Scale and infarct volume. The gene discussed is ICAM3; the disease is Stroke.